ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,277Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 302

$479K Total Retail Price of All Prescriptions

Rank: 20 out of 302

315 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 315 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,502 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $100 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
METOPROLOL TARTRATE 374 366 1 5
AMLODIPINE BESYLATE 365 344 2 2
LISINOPRIL 361 307 3 1
LEVOTHYROXINE SODIUM 250 217 4 9
SIMVASTATIN 248 223 5 3
FUROSEMIDE 241 223 6 4
OMEPRAZOLE 158 143 7 7
JANTOVEN 158 158 7 71
DONEPEZIL HCL 151 151 9 27
ATORVASTATIN CALCIUM 150 148 10 10
WARFARIN SODIUM 148 147 11 8
METFORMIN HCL 146 138 12 13
PANTOPRAZOLE SODIUM 139 125 13 25
MIRTAZAPINE 123 123 14 38
CITALOPRAM HBR 118 96 15 30
TRAZODONE HCL 116 106 16 36
LOVASTATIN 115 89 17 63
CYMBALTA 112 112 18 74
RISPERIDONE 110 86 19 40
PRAVASTATIN SODIUM 110 110 19 17
LANTUS 109 93 21 66
NAMENDA 101 89 22 67
QUETIAPINE FUMARATE 98 98 23 54
METOPROLOL SUCCINATE 93 89 24 6
TRAMADOL HCL 92 89 25 16
DIOVAN 83 83 26 60
CARVEDILOL 81 79 27 19
TAMSULOSIN HCL 79 75 28 41
LACTULOSE 79 72 28 89
GABAPENTIN 77 65 30 18
HYDRALAZINE HCL 76 64 31 48
HYDROCHLOROTHIAZIDE 75 64 32 12
ALLOPURINOL 71 71 33 77
IBUPROFEN 69 65 34 91
DIOVAN HCT 68 59 35 117
CLOZAPINE 67 52 36 109
HYDROCODONE-ACETAMINOPHEN 65 65 S3 37 15
GLIPIZIDE 64 61 38 114
SERTRALINE HCL 64 58 38 43
KLOR-CON M20 62 62 40 107
RANITIDINE HCL 58 55 41 33
ISOSORBIDE MONONITRATE ER 55 55 42 37
CARBIDOPA-LEVODOPA 54 54 43 35
ABILIFY 53 53 44 93
RAMIPRIL 53 53 44 106
CLONIDINE HCL 52 46 46 59
NIFEDIPINE ER 52 52 46 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.